Basics Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care. IPO Date: September 29, 2016 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $733.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 2.90% Avg Daily Range (30 D): $0.28 | 1.22% Avg Daily Range (90 D): $0.26 | 1.26% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 40 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 1,780 Avg Inst. Trade: $1.81M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $.94M Avg Closing Trade (90 D): $.9M Avg Closing Volume: 44.47K     News Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jul 1, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jun 23, 2025 @ 4:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A Jun 10, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating Semle... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 303.22M $ 81.8M $ 73.46M Gross Profit $ 121.4M $ 34.44M $ 28.35M Net Income / Loss $ -52.04M $ -19.26M $ -11.9M Operating Income / Loss $ -72.72M $ -19.71M $ -19.8M Cost of Revenue $ 181.82M $ 47.37M $ 45.12M Net Cash Flow $ 22.9M $ 20.6M $ 12.14M PE Ratio